Volker has been with Exel for seven years, and has been devoted to Life Sciences third party logistics for the last 12. On the business development side of his split role, Volker manages Exel's North American businesses with Novartis and Pfizer. And in his strategic planning role, Volker leads product and new business development which have taken Exel into three new domains since his arrival, transforming Exel from its consumer healthcare focus of 2005. He leads all special projects and is currently developing sector plans for specialty pharma and hospital logistics.
Volker came to Exel from Kuehne Nagel, where he last served as VP of Healthcare Business Development for North America. Prior to K+N, he spent most of his time in sales and product management roles, serving early stage companies in the medical device and technology sectors.
He earned an MBA and a Masters in Mechanical Engineering from RPI. He earned his BS from the University of Virginia, graduating first in his engineering class.